Qualyst Inc.
This article was originally published in Start Up
Executive Summary
Qualyst Inc. offers its ADME and toxicology technologies not on a service model, but as a licensing model for technology and transfer to drug developers. The most fully developed of Qualyst's technologies is B-Clear, which it says is the only in vitro model available to industry today that is predictive of in vivo biliary clearance and excretion.